Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Peggy Lindley was diagnosed with multiple myeloma on Valentine’s Day 2018 by her long-time general practitioner based on her lab results and a 24-hour urine test. Her GP’s mother was actually diagnosed with myeloma a few years before, so he knew what he was seeing. However, he sent her to have a bone marrow biopsy, and that confirmed the prognosis. Peggy asked for a second opinion on her lab work, and that second opinion paperwork showed the translocation 4:14. Peggy then started induction therapy of lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone (Decadron) for five rounds along with two zoledronic acid (Zometa) injections. Peggy’s insurance allowed her to go to MD Anderson Cancer Center to start the stem cell process. She had an autologous stem cell transplant in July of 2018 and is now on a clinical trial. She doesn’t think she had genetic testing done but knows she has the translocation 4:14.